의료 데이터 분석 및 예측 모델링 시장 예측(-2034년) : 구성요소, 분석 유형, 도입 모델, 용도, 최종사용자 및 지역별 분석

According to Stratistics MRC, the Global Healthcare Data Analytics & Predictive Modeling Market is accounted for $25.9 billion in 2026 and is expected to reach $178.6 billion by 2034 growing at a CAGR of 27.3% during the forecast period. Healthcare Data Analytics & Predictive Modeling applies clinical, administrative, financial, and patient data to uncover insights and forecast potential healthcare outcomes. It integrates artificial intelligence, machine learning, statistical techniques, and predictive models to assist with risk identification, continuous patient monitoring, resource allocation, operational planning, and individualized treatment strategies. The expansion of digital health systems, electronic medical records, connected devices, and evidence-based decision-making is accelerating adoption among healthcare organizations. Advanced analytics can help providers detect emerging risks earlier, streamline operations, improve resource utilization, and strengthen the delivery of personalized and efficient healthcare services.

According to the Office of the National Coordinator for Health Information Technology (ONC), 71% of U.S. hospitals reported using predictive AI integrated with electronic health records in 2024, compared with 66% in 2023. The data demonstrates increasing adoption of predictive technologies within hospital healthcare workflows and supports the growing need for healthcare analytics and predictive modeling solutions.

Market Dynamics:

Driver:

Growing adoption of electronic health records

Increasing use of electronic health records (EHRs) is accelerating demand for Healthcare Data Analytics & Predictive Modeling solutions. EHR platforms collect substantial volumes of clinical information, covering diagnoses, test results, prescriptions, treatment records, and patient outcomes. Analyzing these datasets helps healthcare providers recognize patterns, strengthen decision-making, monitor patients, and manage resources more effectively. Continued digitalization of healthcare infrastructure is encouraging integration between EHR systems and advanced analytics tools, allowing organizations to convert stored information into practical insights while supporting data-driven clinical practices and improving overall operational efficiency.

Restraint:

Data privacy and security concerns

Concerns surrounding patient data privacy and cybersecurity may limit adoption of Healthcare Data Analytics & Predictive Modeling solutions. Healthcare providers handle sensitive information such as clinical histories, diagnostic results, and personal details, making analytics environments potential targets for cyber threats and unauthorized access. Organizations therefore require strong security infrastructure, data governance, and regulatory compliance procedures. Meeting these requirements can increase deployment costs and operational complexity. Smaller healthcare organizations may face greater challenges because they often have fewer financial, technical, and cybersecurity resources available for advanced analytics implementation.

Opportunity:

Integration of artificial intelligence and machine learning

Artificial intelligence (AI) and machine learning (ML) integration offers considerable opportunities for Healthcare Data Analytics & Predictive Modeling solutions. AI-based platforms can evaluate extensive healthcare datasets, recognize patterns, forecast health risks, and assist medical decision-making. Machine learning systems can improve their predictive performance as additional data becomes available. Healthcare providers are increasingly applying these technologies to personalized treatment, early identification of diseases, patient risk assessment, and operational planning. This expanding adoption creates opportunities for analytics companies to develop sophisticated predictive solutions tailored to healthcare requirements.

Threat:

Increasing cybersecurity risks and data breaches

Growing cybersecurity threats and data breaches can challenge the Healthcare Data Analytics & Predictive Modeling Market. Healthcare providers manage substantial amounts of confidential patient and clinical information, making analytical systems vulnerable to cyberattacks. Ransomware incidents, unauthorized system access, and information theft can interrupt healthcare operations and reduce trust in digital technologies. Such incidents can also result in regulatory and financial consequences. As a result, providers may introduce more stringent security measures or postpone analytics investments, potentially slowing the implementation and expansion of predictive healthcare technologies.

Covid-19 Impact:

COVID-19 significantly encouraged healthcare organizations to adopt analytics and predictive modeling for patient care, resource planning, disease surveillance, and demand forecasting. Greater reliance on telehealth, electronic medical records, remote patient monitoring, and digital healthcare services increased the availability of patient data. Healthcare providers used analytical tools to monitor trends, evaluate hospital capacity, and plan essential resources. The pandemic demonstrated the value of real-time information and forecasting technologies, motivating organizations to enhance digital healthcare infrastructure and incorporate data-driven approaches into clinical and operational decision-making.

The software platforms segment is expected to be the largest during the forecast period

The software platforms segment is expected to account for the largest market share during the forecast period because they form the technological foundation for healthcare data management, analytics, and predictive modelling. They allow organizations to consolidate process, visualize, and interpret information from multiple healthcare sources while supporting artificial intelligence and machine learning capabilities. Their ability to provide flexible and integrated analytics environments makes them increasingly important for healthcare organizations seeking to convert complex data into actionable insights and support data-driven healthcare operations.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical & biotechnology companies segment is predicted to witness the highest growth rate become increasingly important in drug development, clinical research, and precision medicine. Organizations handle complex information from clinical trials, laboratory studies, real-world evidence, and patient outcomes. Advanced predictive tools can support drug candidate identification, optimize clinical trial planning, evaluate treatment effectiveness, and streamline research activities. The expanding focus on personalized therapies and evidence-based pharmaceutical innovation is encouraging greater adoption of healthcare analytics technologies across pharmaceutical and biotechnology organizations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by sophisticated healthcare systems, extensive digitalization, and strong adoption of electronic health records and predictive technologies. Healthcare organizations increasingly apply analytics for patient monitoring, risk identification, clinical decisions, resource management, and population health programs. The region has a mature health technology ecosystem that supports integration of advanced analytical solutions. In the United States, 71% of hospitals reported using predictive AI integrated with EHRs in 2024, demonstrating substantial adoption of technologies supporting data-driven healthcare.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by accelerating digital transformation and broader adoption of electronic health records, AI, and machine learning. Healthcare providers are developing stronger data capabilities to support clinical decisions, patient monitoring, and population health initiatives. Increasing investment in cloud infrastructure, digital health platforms, and predictive technologies is encouraging adoption throughout the region. Expanding healthcare technology ecosystems and modernization efforts are creating favorable conditions for advanced analytics and predictive modeling solutions.

Key players in the market

Some of the key players in Healthcare Data Analytics & Predictive Modeling Market include Optum, IBM Corporation, Oracle Health, SAS Institute, IQVIA, McKesson Corporation, Epic Systems Corporation, Health Catalyst, Inovalon, Arcadia, MedeAnalytics, CitiusTech, Innovaccer, Clarify Health, Cotiviti, Veradigm, Cognizant and EXL.

Key Developments:

In June 2026, Oracle Health and Theator are working together to provide AI-powered surgical intelligence solutions to Oracle Health customers in the U.S. With Theator's solutions, which capture surgical video footage and use AI to analyze it and cross-reference EHR data, surgical teams can benefit from automated reporting that is more clinically accurate, optimized for billing, and tailored to individual preferences, with no transcription or dictation required.

In December 2025, IBM and Confluent, Inc. announced they have entered into a definitive agreement under which IBM will acquire all of the issued and outstanding common shares of Confluent for $31 per share, representing an enterprise value of $11 billion. Confluent provides a leading open-source enterprise data streaming platform that connects processes and governs reusable and reliable data and events in real time, foundational for the deployment of AI.

Components Covered:

• Software Platforms
• Services
• Hardware & Infrastructure

Analytics Types Covered:

• Descriptive Analytics
• Diagnostic Analytics
• Predictive Analytics
• Prescriptive Analytics

Deployment Models Covered:

• On-Premise
• Cloud-Based
• Hybrid

Applications Covered:

• Clinical Data Analytics
• Financial Analytics
• Operational & Administrative Analytics
• Population Health Analytics
• Risk Management & Fraud Detection

End Users Covered:

• Hospitals & Healthcare Providers
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutions
• Payers
• Government & Public Health Agencies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Data Analytics & Predictive Modeling Market, By Component

• 5.1 Software Platforms
• 5.2 Services
• 5.3 Hardware & Infrastructure

6 Global Healthcare Data Analytics & Predictive Modeling Market, By Analytics Type

• 6.1 Descriptive Analytics
• 6.2 Diagnostic Analytics
• 6.3 Predictive Analytics
• 6.4 Prescriptive Analytics

7 Global Healthcare Data Analytics & Predictive Modeling Market, By Deployment Model

• 7.1 On-Premise
• 7.2 Cloud-Based
• 7.3 Hybrid

8 Global Healthcare Data Analytics & Predictive Modeling Market, By Application

• 8.1 Clinical Data Analytics
• 8.2 Financial Analytics
• 8.3 Operational & Administrative Analytics
• 8.4 Population Health Analytics
• 8.5 Risk Management & Fraud Detection

9 Global Healthcare Data Analytics & Predictive Modeling Market, By End User

• 9.1 Hospitals & Healthcare Providers
• 9.2 Pharmaceutical & Biotechnology Companies
• 9.3 Research & Academic Institutions
• 9.4 Payers
• 9.5 Government & Public Health Agencies

10 Global Healthcare Data Analytics & Predictive Modeling Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Optum
• 13.2 IBM Corporation
• 13.3 Oracle Health
• 13.4 SAS Institute
• 13.5 IQVIA
• 13.6 McKesson Corporation
• 13.7 Epic Systems Corporation
• 13.8 Health Catalyst
• 13.9 Inovalon
• 13.10 Arcadia
• 13.11 MedeAnalytics
• 13.12 CitiusTech
• 13.13 Innovaccer
• 13.14 Clarify Health
• 13.15 Cotiviti
• 13.16 Veradigm
• 13.17 Cognizant
• 13.18 EXL